Status:
COMPLETED
Action Observation Training With 3D Virtual Reality in Patients With Multiple Sclerosis
Lead Sponsor:
Abant Izzet Baysal University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Multiple sclerosis is a chronic, autoimmune and inflammatory disease of the Central Nervous System characterized by neuronal demyelination and axonal degeneration. Upper extremity problems are present...
Detailed Description
The training will involve watching 3D videos of upper limb functions in VR and then repeating the functions by the participants. The AOT group will watch video sequences involving upper limb functions...
Eligibility Criteria
Inclusion
- \< 2 years MS diagnosis according to McDonald criteria
- between 3.5 and 6 the EDSS
- Nine Hole Peg Test \> 30s for at least one upper extremity
- no change in medication in the last 6 months
- having MS disease with ongoing attacks
- \>2 Modified Ashworth Scale in the upper extremities
- MOCA\>25
Exclusion
- diagnosed with neurological (except MS), cardiopulmonary, metabolic or musculoskeletal disease that would prevent treatment and evaluation
- receiving botulinum toxin treatment in the last 6 months
- visual impairment uncorrected by optical devices
- inability to adapt to treatment based on 3D immersive virtual reality (e.g. with cognitive impairment, communication problems, psychological problems or vestibular system problems)
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 2 2025
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06107023
Start Date
November 15 2023
End Date
March 2 2025
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Izzet Baysal University
Bolu, Center, Turkey (Türkiye), 14030